Education
About Us
Working with TipRanks
Follow Us
CVRx (CVRX)
NASDAQ:CVRX
CVRX Stock Chart & Stats
$8.03
-$0.03(-0.21%)
At close: 4:00 PM EST
$8.03
-$0.03(-0.21%)
Day’s Range― - ―
52-Week Range$4.30 - $18.55
Previous CloseN/A
Volume20.10K
Average Volume (3M)201.62K
Market Cap
$210.47M
Enterprise Value$176.58M
Total Cash (Recent Filing)$85.12M
Total Debt (Recent Filing)$50.18M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Jan 22, 2026EPS Estimate
-0.44Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.49
Shares Outstanding26,210,110
10 Day Avg. Volume152,794
30 Day Avg. Volume201,618
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)4.03
Price to Sales (P/S)5.58
P/FCF Ratio-7.07
Enterprise Value/Market Cap0.84
Enterprise Value/Revenue3.15
Enterprise Value/Gross Profit3.71
Enterprise Value/Ebitda-3.89
Forecast
1Y Price Target
$12.67Price Target Upside57.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-2.03
Revenue Forecast (FY)$56.13M
Bulls Say, Bears Say
Bulls Say
Clinical Trial ExpansionBENEFIT-HF was recently posted to clinicaltrials.gov, reaching another milestone for the company’s clinical and commercial efforts.
Financial PerformanceCVRX reported Q3/25 revenue of $14.7M, ahead of analyst estimates and consensus, indicating positive performance.
Reimbursement StabilityCMS kept CVRX’s Barostim procedure assigned to New Technology APC 1580, indicating stability.
Bears Say
Sales Rep TurnoverIncreased sales rep turnover and changes in its commercial organization may have a prolonged negative impact on results.
CVRx News
CVRX FAQ
What was CVRx’s price range in the past 12 months?
CVRx lowest stock price was $4.30 and its highest was $18.55 in the past 12 months.
What is CVRx’s market cap?
CVRx’s market cap is $210.47M.
When is CVRx’s upcoming earnings report date?
CVRx’s upcoming earnings report date is Jan 22, 2026 which is in 32 days.
How were CVRx’s earnings last quarter?
CVRx released its earnings results on Nov 05, 2025. The company reported -$0.49 earnings per share for the quarter, beating the consensus estimate of -$0.493 by $0.003.
Is CVRx overvalued?
According to Wall Street analysts CVRx’s price is currently Undervalued.
Does CVRx pay dividends?
CVRx does not currently pay dividends.
What is CVRx’s EPS estimate?
CVRx’s EPS estimate is -0.44.
How many shares outstanding does CVRx have?
CVRx has 26,210,110 shares outstanding.
What happened to CVRx’s price movement after its last earnings report?
CVRx reported an EPS of -$0.49 in its last earnings report, beating expectations of -$0.493. Following the earnings report the stock price went up 2.656%.
Which hedge fund is a major shareholder of CVRx?
Currently, no hedge funds are holding shares in CVRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.67 (57.78% Upside)
$12.67 (57.78% Upside)
Blogger Sentiment
Bullish
CVRX Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 68.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $637.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-31.48%
12-Months-Change
Fundamentals
Return on Equity
-91.88%
Trailing 12-Months
Asset Growth
-12.80%
Trailing 12-Months
Company Description
CVRx
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
CVRX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects substantial progress with a notable increase in revenue, expanded commercial footprint, and improved gross margins. However, challenges remain with increased R&D expenses, higher interest expenses, and a net loss. The positive developments in clinical evidence and approval of a Category I CPT code are promising for future growth.View all CVRX earnings summariesCVRX Stock 12 Month Forecast
Average Price Target
$12.67
▲(57.78% Upside)
Technical Analysis
Ownership Overview
26.97% Insiders
6.49% Mutual Funds
29.48% Other Institutional Investors
30.88% Public Companies and
Individual Investors